share_log
Moomoo 24/7 ·  03/12 06:11

Ideaya Biosciences Has Entered Into A Clinical Trial Collaboration And Supply Agreement With Merck To Evaluate Its IDEE161 In Combination With Keytruda (Pembrolizumab) For Endometrial Cancer, In A Phase 1 Trial

Ideaya Biosciences已與默沙東簽訂了臨床試驗合作和供應協議,以評估其 IDEE161 與 Keytruda(Pembrolizumab)聯合用於子宮內膜癌的 1 期試驗

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論